ASCO: MRIs, contrast-enhanced mammography useful for small breast tumors
“There is a real need to detect cancers that are small [less than 1 cm] before they metastasize. That would be the Holy Grail.”
Syapse’s Precision Cancer Network boosts collective wisdom through genomic data sharing
The network enables comprising 79 hospitals in 11 states to share anonymous cancer patient genomic data.
Navigating The Right Steps For Your Healthcare Startup
This webinar will explore how a banking platform approach could be the resource for your company.
Myriad touts studies at ASCO that back its transition toward panel testing for hereditary cancer
The market leader in cancer panel gene testing flooded the zone at the annual meeting of the American Society of Clinical Oncology in Chicago.
ASCO: Newly approved drug for renal cell carcinoma lowers death rate
Patients with previously treated advanced renal cell carcinoma have a new treatment option with cabozantinib — a kinase inhibitor shown to improve overall survival compared to everolimus, as a Cleveland Clinic researcher noted at ASCO 2016 over the weekend.
ASCO: Cleveland Clinic shares new ideas for targeted therapy of brain metastasis
At ASCO 2016, Cleveland Clinic researchers examined the impact of the number of brain metastases on overall survival for two common cancer types: Non-small cell lung cancer and gastroesophageal cancer.
Patient advocates launch offensive against ICER over drug costs
A forum convened by patient advocates will serve as the launching event for the ICER Watch patient portal, which will track the movements of the Institute for Clinical and Economic Review, which last month released a report on the effectiveness of treatment options for multiple myeloma.
presented by
How to Optimize Your Phlebotomy Setup for Efficient Patient Care
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
At ASCO15 meeting: Breakthrough melanoma treatment, Memorial Sloan Kettering oncologist slams cancer drug price tags (Morning Read)
Bristol-Myers Squibb revealed results of Phase 3 study of combined melanoma treatment that could be a cancer treatment breakthrough, but comes with a big price tag and side effects.
Bayer gives $1M to ASCO’s big data effort
The American Society of Clinical Oncology‘s effort to use big data and EHRs to earlier detect cancer just got a $1 million boost from pharma giant Bayer Healthcare. The Society, better known as ASCO, recently launched the effort dubbed CancerLinQ with Germany-based SAP, creating what’s described as an IT platform “designed to unlock vast quantities […]
Study: Unjustified cancer treatments are driving up healthcare costs
A study evaluating cancer treatment regimens prescribed to patients across the country has come away with the conclusion that billions are wasted on what are referred to as nonevidence-based cancer treatments. Philadelphia-based eviti conducted the three-year study with the Abramson Cancer Center at the University of Pennsylvania and Johns Hopkins Carey Business School, according to […]
A View to a Cure for Prostate Cancer
According to the CDC, prostate cancer represents the most common non-skin cancer in American men and the second leading cause of death in US men. Recent research initiatives have shed some light on the mechanisms of this disease and possible therapies for treating both localized and metastatic prostate cancers. Even so, researchers and scientists remain […]
presented by
The Top Surgical Instruments Needed for Extractions
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.